Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
Julie M ShabtoDylan J MartiniYuan LiuDeepak RavindranathanJacqueline BrownEmilie E HitronGreta A RusslerSarah CaulfieldHaydn KissickMehrdad AlemozaffarKenneth OganWayne B HarrisViraj A MasterOmer KucukBradley C CarthonMehmet Asim BilenPublished in: Cancer medicine (2020)
Risk scoring using baseline PLR, presence of liver metastasis, baseline albumin, and baseline ECOG PS may effectively predict OS and PFS in UC patients receiving ICI.